Global Bifurcation Lesions Treatment Market Overview
A bifurcation lesion is a constriction of a coronary artery that occurs near and/or involves the origin of a substantial side branch that you don't want to lose. The Medina classification is intended for use in clinical research and interchange. It is connected with several measuring and imaging modalities that take into consideration the complexity of lesions and therapies, as well as a clear side branch delineation. Measurement of the bifurcation angles requires specialised angiography, as well as 3D angiography and multislice computed tomography. The MADS classification is based on the final position of the stents in the bifurcation and the order in which stents are implanted according to a strategy reflecting lesion and procedure complexity. Although this categorization appears to be comprehensive, it excludes the multiple guide and balloon manoeuvres, which would necessitate a comprehensive a posteriori electronic classification. The Global Bifurcation Lesions Treatment Market accounted for US$ 2.06 billion in 2020 and is estimated to be US$ 3.44 billion by 2030 and is anticipated to register a CAGR of 5.30%.
Global Bifurcation Lesions Treatment Market Dynamics
Increased insurance coverage for bifurcation lesion operations will drive the growth of the Market
Commercialization of novel devices, increased insurance coverage for bifurcation lesion operations, and improved imaging modalities are driving the industry.
In addition, ongoing clinical trials on stents and balloons for bifurcation lesions, as well as an increase in the occurrence of these lesions, are expected to boost the market in the future years. Advancements in imaging and procedure devices, as well as an increase in the number of qualified surgeons, have reduced related risks, which is expected to boost the market forward.
Global Bifurcation Lesions Treatment Market Segmentation
The Global Bifurcation Lesions Treatment Market is segmented based on type, product and region.
On the basis of Product, the Global Bifurcation Lesions Treatment Market is segmented into T Stent, Culottes, Crush, V Stent, Y Stent, and Jailed Balloon. Based on Type, the target market is segmented into Coronary Vascular, Peripheral Vascular.
Regional Insights:
On region the Global Bifurcation Lesions Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2020, the market for bifurcation lesions was dominated by North America. During the forecast period, the region is expected to maintain its dominance. This is due to the presence of large market participants on the ground, increased disposable money, and attractive reimbursement rules. Due to the existence of industry companies and government attempts to increase healthcare access, Europe accounted for the second-largest proportion. Due to an increase in the senior population and obesity, which has led in an increase in coronary heart illnesses, the Asia Pacific area is expected to grow at the quickest rate during the projection period. Furthermore, increased awareness and acceptance of newer technologies, as well as the approval of various balloons and the entry of foreign and new regional market competitors, are projected to promote regional growth.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Product- T Stent, Culottes, Crush, V Stent, Y Stent, Jailed Balloon By Type– Coronary Vascular, Peripheral Vascular |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Bifurcation Lesions Treatment Market report based on type, product and region.
Global Bifurcation Lesions Treatment Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Bifurcation Lesions Treatment Market Key Players
The key players operating in the bifurcation lesions treatment market are Boston Scientific Corporation; Abbott; Cardinal Health; Medtronic; C. R. Bard, Inc.; Johnson & Johnson Services, Inc.; Spectranetics; and Terumo Medical Corporation.
Global Bifurcation Lesions Treatment Market Company Profile
- Boston Scientific Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cardinal Health
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Medtronic
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- C. R. Bard, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Johnson & Johnson Services, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Terumo Medical Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Spectranetics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Bifurcation Lesions Treatment Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for Bifurcation lesions treatment Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product
- Market Snippet, By Type
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Product, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- T Stent
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Culottes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Crush
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- V Stent
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Y Stent
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Jailed Balloon
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Coronary Vascular
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Peripheral Vascular
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Boston Scientific Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cardinal Health
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Medtronic
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- C. R. Bard, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Johnson & Johnson Services, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Terumo Medical Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Spectranetics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
Global Bifurcation Lesions Treatment Market Highlights
FAQs
Global Bifurcation Lesions Treatment Market is segmented based on product, type and region.
Increased insurance coverage for bifurcation lesion operations is major factor driving the market.
During the forecast period, North America is expected to dominate the market.
The key players operating in the bifurcation lesions treatment market are Boston Scientific Corporation; Abbott; Cardinal Health; Medtronic; C. R. Bard, Inc.; Johnson & Johnson Services, Inc.; Spectranetics; and Terumo Medical Corporation.